Dolby Laboratories DLB
Valuation
Multiples measured against the stock's own five-year history
Below its usual level · 25th percentile, 5-year average 32.9x
#2031 of 2994 stocks by PE (1 = cheapest)
Near the bottom of its 5-year range · 12th percentile, 5-year average 2.9x
#3335 of 5331 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 12th percentile, 5-year average 5.6x
#3780 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 2.31 | – | 2.92 | 12% (cheaper than usual) | #3335 of 5331 (1 = cheapest) |
| PE | 27.07 | 20.96 | 32.90 | 25% (cheaper than usual) | #2031 of 2994 (1 = cheapest) |
| PS | 4.40 | 4.09 | 5.59 | 12% (cheaper than usual) | #3780 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on DLB.
Sign in to join the discussion.